Patten & Patten Inc/Tn’s Abbott Laboratories Position
Does Patten & Patten Inc/Tn own Abbott Laboratories (ABT)? Yes — 136.9K shares worth $14M (+0.85% of its 13F portfolio) as of Q1 2026, down from 140.5K shares the prior filed quarter.
Position Value
$14M
Q1 2026
Shares
136.9K
% of Portfolio
+0.85%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 136.9K | $14M | +0.85% |
| Q4 2025 | 140.5K | $18M | +1.03% |
| Q3 2025 | 147.4K | $20M | +1.16% |
| Q2 2025 | 150.7K | $20M | +1.33% |
| Q1 2025 | 159.1K | $21M | +1.41% |
| Q4 2024 | 160.5K | $18M | +1.20% |
| Q3 2024 | 164.2K | $19M | +1.24% |
| Q2 2024 | 166.0K | $17M | +1.21% |
| Q1 2024 | 168.7K | $19M | +1.37% |
| Q4 2023 | 167.2K | $18M | +1.51% |
| Q3 2023 | 184.7K | $18M | +1.57% |
| Q2 2023 | 187.4K | $20M | +1.69% |
| Q1 2023 | 186.9K | $19M | +1.66% |
| Q4 2022 | 187.5K | $20,589 | +1.87% |
| Q3 2022 | 189.7K | $18M | +1.74% |
| Q2 2022 | 192.2K | $21M | +1.83% |
| Q1 2022 | 197.9K | $23M | +1.71% |
| Q4 2021 | 197.0K | $28M | +1.92% |
| Q3 2021 | 196.6K | $23M | +1.77% |
| Q2 2021 | 197.1K | $23M | +1.74% |
| Q1 2021 | 203.6K | $24M | +2.00% |
| Q4 2020 | 204.2K | $22M | +1.95% |
| Q3 2020 | 204.2K | $22M | +2.21% |
| Q2 2020 | 206.0K | $19M | +2.06% |
| Q1 2020 | 208.3K | $16M | +2.17% |
| Q4 2019 | 212.0K | $18M | +1.85% |
| Q3 2019 | 211.5K | $18M | +1.93% |
| Q2 2019 | 213.1K | $18M | +1.94% |
| Q1 2019 | 215.9K | $17M | +1.89% |
| Q4 2018 | 216.1K | $16M | +1.92% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Patten & Patten Inc/Tn’s full portfolio or all institutional holders of ABT.